CJC-1295 with DAC 5mg

All compounds and related materials are supplied as a complete research package and are provided strictly for laboratory research use only. This includes all necessary related materials (such as bacteriostatic water, syringes, and accessories) for research preparation. They are not intended for human or veterinary use, medical diagnosis, treatment, or any form of self-administration.

CJC-1295 with DAC 5 mg – Research Peptide for Growth Hormone Modulation

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed to prolong the natural secretion of growth hormone through sustained pituitary stimulation. The DAC modification allows strong binding to serum albumin, resulting in significantly extended half-life and bioavailability compared to CJC-1295 without DAC. Supplied as a lyophilized (freeze-dried) peptide to ensure optimal stability under controlled laboratory conditions.

Historical Background and Scientific Context

CJC-1295 with DAC was first synthesized in the early 2000s by Canadian researchers seeking long-acting analogues of GHRH for controlled hormone modulation. Between 2005 and 2024, CJC-1295 DAC became a reference compound in research investigating growth hormone release, endocrine aging, and tissue regeneration mechanisms. Its long half-life and steady serum profile make it a key model peptide for studying growth-factor pathways and hormonal balance in laboratory environments.

Mechanistic Focus in Research

Within scientific research, CJC-1295 DAC is examined for its ability to enhance GH and IGF-1 production by extending receptor activation duration. Laboratory models explore dose-response behavior, cellular protein synthesis, and recovery signaling. It remains a widely studied peptide in the field of growth modulation and regenerative metabolism.

Analytical Verification (COA)

Laboratory: Liquilabs s.r.o., Czechia
Batch Number: GF102025048
Date Published: 12 October 2025
Identity (RT): 0.997 ± 0.005 confirmed by spectrum (994 ± 20)
Content: 5.50 mg ± 0.03 mg per vial
Purity: ≥ 99.8 %
Bioburden: Not detected (USP <61>)
Endotoxin: < 0.01 EU/mg (USP <85>)
Heavy Metals: Not detected (As, Pb, Cd, Hg, Ni, Co, V)

Research Applications

– Investigation of GH and IGF-1 modulation mechanisms
– Peptide stability and half-life extension models
– Studies on cellular recovery and protein synthesis
– Endocrine aging and metabolic regulation research

Grail Formula Quality – From 24PEPTIDES

Every Grail Formula peptide is independently verified by Liquilabs for identity, purity, and safety. Each batch is fully traceable and documented for research-grade reproducibility. All products are supplied as lyophilized powders for long-term stability and precision.

When you choose Grail Formula CJC-1295 with DAC 5 mg…

…you receive a research-grade peptide validated for ≥99.8% purity and analytical accuracy. Delivered as a complete research package — everything included to initiate your studies immediately in a controlled laboratory setting.

⚠ Research Use Only

This compound and all related materials are intended solely for scientific and laboratory research. They are not approved for diagnostic or therapeutic use and must not be self-administered. Always handle with protective equipment and follow institutional safety protocols.

• High-purity CJC-1295 with DAC (≥99.8%)

• COA verified by Liquilabs s.r.o. (Czechia)

• Lyophilized (freeze-dried) for stability and long shelf life

• Free from microbial contamination and endotoxins

• Heavy metals not detected

• Delivered as a complete research package

• For research use only

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.